In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Migalastat Drug Master File in Korea (Migalastat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Migalastat. The MFDS reviews the Migalastat KDMF as part of the drug registration process and uses the information provided in the Migalastat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Migalastat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Migalastat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Migalastat suppliers with KDMF on PharmaCompass.